Pune, India

Ganesh Suryakant Deore

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hikal Limited. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ganesh Suryakant Deore. Retrieved from https://idiyas.com/inventor/ganesh-suryakant-deore

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ganesh Suryakant Deore: Innovator in Pharmaceutical Processes

Introduction

Ganesh Suryakant Deore is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for drug preparation. His work exemplifies the innovative spirit that drives advancements in medical science.

Latest Patents

Ganesh Suryakant Deore holds a patent for a process related to the preparation of Butorphanol tartrate. This invention presents an improved method for synthesizing Butorphanol tartrate, which is crucial in the pharmaceutical industry for pain management.

Career Highlights

Deore is associated with Hikal Limited, a company known for its expertise in pharmaceutical and agrochemical manufacturing. His role at Hikal Limited has allowed him to apply his innovative ideas in a practical setting, contributing to the company's success in the industry.

Collaborations

Throughout his career, Ganesh has collaborated with talented professionals such as Rahul Bhalerao and R Sridharan. These collaborations have fostered a creative environment that encourages the exchange of ideas and enhances the development of new technologies.

Conclusion

Ganesh Suryakant Deore's contributions to pharmaceutical processes highlight his role as an innovator in the industry. His patent for Butorphanol tartrate preparation showcases his commitment to improving drug development methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…